Literature DB >> 6732312

Priority of revascularization in patients with graft enteric fistulas, infected arteries, or infected arterial prostheses.

H H Trout, L Kozloff, J M Giordano.   

Abstract

Patients with arterial infections, infected arterial prostheses, or graft enteric erosions or fistulas have high amputation and mortality rates after treatment. An unresolved therapeutic question is whether remote ("extra-anatomic") bypass should precede or follow removal of the infected artery or prosthesis. None of the ten patients reported here who had a remote bypass inserted first developed distal limb ischemia or infection of the remote bypass. Literature review of patients with aortic prosthetic infections revealed a mortality of 71% (10/14) if infected graft removal preceded remote bypass and 26% (6/23) if remote bypass was first. Patients with graft enteric erosions or fistulas had a mortality of 53% (40/75) if graft removal was first and 17% (5/29) if remote bypass was first. Subsequent infection of the remote bypass was rare. Therefore, when possible, remote bypass with a prosthetic graft should precede removal of an infected artery, an infected arterial prosthesis, a graft enteric erosion, or a graft enteric fistula.

Entities:  

Mesh:

Year:  1984        PMID: 6732312      PMCID: PMC1353444          DOI: 10.1097/00000658-198406000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  79 in total

1.  Infected arterial grafts: experince in 22 cases with empsis on unusual bactia and technics.

Authors:  J H Conn; J D Hardy; C M Chavez; W R Fain
Journal:  Ann Surg       Date:  1970-05       Impact factor: 12.969

2.  Experimental protection of vascular prosthesis by omentum.

Authors:  H S Goldsmith; R De los Santos; E J Beattie
Journal:  Arch Surg       Date:  1968-12

3.  Subcutaneous arterial bypass grafts in the managment of fistulae between the bowel and plastic arterial prostheses.

Authors:  W K Ehrenfeld; R S Lord; R J Stoney; E J Wylie
Journal:  Ann Surg       Date:  1968-07       Impact factor: 12.969

4.  Axillofemoral bypass graft. A safe alternative to aortoiliac reconstruction.

Authors:  J A Mannick; D C Nabseth
Journal:  N Engl J Med       Date:  1968-02-29       Impact factor: 91.245

5.  Axillofemoral bypass graft.

Authors:  J L Graziano; P B Dobrin
Journal:  Vasc Surg       Date:  1970-06

6.  Treatment of infected aortofemoral arterial prosthesis.

Authors:  E B Diethrich; G P Noon; J E Liddicoat; M E De Bakey
Journal:  Surgery       Date:  1970-12       Impact factor: 3.982

7.  Use of bilateral axillofemoral bypass prosthesis for the management of infected aortic bifurcation grafts: report of a case with extended follow-up.

Authors:  L F Urdaneta; K Visudh-Arom; J P Delaney; A R Castaneda
Journal:  Surgery       Date:  1969-05       Impact factor: 3.982

8.  Axillofemoral bypass in the management of infected aortic bifurcation "dacron" graft.

Authors:  I D Vellar; J C Doyle
Journal:  Aust N Z J Surg       Date:  1970-08

9.  Infection complicating the use of plastic arterial implants.

Authors:  W J Fry; S M Lindenauer
Journal:  Arch Surg       Date:  1967-05

10.  Aorto-enteric fistula.

Authors:  T J Donovan; C A Bucknam
Journal:  Arch Surg       Date:  1967-11
View more
  4 in total

1.  Infected aortic aneurysms. A changing entity.

Authors:  M N Gomes; P L Choyke; R B Wallace
Journal:  Ann Surg       Date:  1992-05       Impact factor: 12.969

2.  The coexistence of abdominal aortic aneurysm and early gastric cancer: report of three cases.

Authors:  H Konno; K Koyano; T Hachiya; S Nakamura; S Baba; S Sakaguchi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Management of infected vascular prostheses. The vascular homograft revisited.

Authors:  P Julia; V A Jebara; P Desgranges; P Dervanian; M de S Uva; C Acar; J N Fabiani
Journal:  Tex Heart Inst J       Date:  1991

4.  Creation of a neo-aortoiliac system from lower extremity deep and superficial veins.

Authors:  G P Clagett; B L Bowers; M A Lopez-Viego; M B Rossi; R J Valentine; S I Myers; A Chervu
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.